• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A. 2015 Jul 13. pii: 201510816. [Epub ahead of print]
[h=1]Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.[/h] Xiong X[SUP]1[/SUP], Corti D[SUP]2[/SUP], Liu J[SUP]3[/SUP], Pinna D[SUP]2[/SUP], Foglierini M[SUP]2[/SUP], Calder LJ[SUP]1[/SUP], Martin SR[SUP]4[/SUP], Lin YP[SUP]1[/SUP], Walker PA[SUP]4[/SUP], Collins PJ[SUP]1[/SUP], Monne I[SUP]5[/SUP], Suguitan AL Jr[SUP]6[/SUP], Santos C[SUP]6[/SUP], Temperton NJ[SUP]7[/SUP], Subbarao K[SUP]6[/SUP], Lanzavecchia A[SUP]2[/SUP], Gamblin SJ[SUP]1[/SUP], Skehel JJ[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] H5N1 avian influenza viruses remain a threat to public health mainly because they can cause severe infections in humans. These viruses are widespread in birds, and they vary in antigenicity forming three major clades and numerous antigenic variants. The most important features of the human monoclonal antibody FLD194 studied here are its broad specificity for all major clades of H5 influenza HAs, its high affinity, and its ability to block virus infection, in vitro and in vivo. As a consequence, this antibody may be suitable for anti-H5 therapy and as a component of stockpiles, together with other antiviral agents, for health authorities to use if an appropriate vaccine was not available. Our mutation and structural analyses indicate that the antibody recognizes a relatively conserved site near the membrane distal tip of HA, near to, but distinct from, the receptor-binding site. Our analyses also suggest that the mechanism of infectivity neutralization involves prevention of receptor recognition as a result of steric hindrance by the Fc part of the antibody. Structural analyses by EM indicate that three Fab fragments are bound to each HA trimer. The structure revealed by X-ray crystallography is of an HA monomer bound by one Fab. The monomer has some similarities to HA in the fusion pH conformation, and the monomer's formation, which results from the presence of isopropanol in the crystallization solvent, contributes to considerations of the process of change in conformation required for membrane fusion.


[h=4]KEYWORDS:[/h] H5N1; influenza virus; neutralizing antibody

PMID: 26170284 [PubMed - as supplied by publisher] Free full text
 
Back
Top Bottom